• The time to offer treatments for COVID-19 

      Ngo, Binh T.; Marik, Paul; Kory, Pierre; Shapiro, Leland; Thomadsen, Raphael; Iglesias, Jose; Ditmore, Stephen; Rendell, Marc; Varon, Joseph; Dube, Michael; Nanda, Neha; In, Gino K.; Arkfeld, Daniel; Chaudhary, Preet; Campese, Vito M.; Hanna, Diana L.; Sawcer, David E.; Ehresmann, Glenn; Peng, David; Smorgorzewski, Miroslaw; Armstrong, April; Dasgupta, Rajkumar; Sattler, Fred R.; Brennan-Rieder, Denise; Mussini, Cristina; Mitjà, Oriol; Soriano, Vicente (1); Peschanski, Nicolas; Hayem, Gilles; Confalonieri, Marco; Piccirillo, Maria Carmela; Lobo-Ferreira, António; Bello Rivero, Iraldo; Turkia, Mika; Vinjevoll, Eivind H.; Griffin, Daniel O.; Hung, Ivan Fn (Expert opinion on investigational drugs, 2021)
      Background: COVID-19 has several overlapping phases. Treatments to date have focused on the late stage of disease in hospital. Yet, the pandemic is by propagated by the viral phase in out-patients. The current public health ...